Hernández Prats Carmen, Llinares Tello Francisca, Burgos San José Amparo, Selva Otaolaurruchi Juan, Ordovás Baines Juan Pablo
Pharmacy Department, Alicante University General Hospital, Alicante, Spain.
Ann Pharmacother. 2004 Mar;38(3):414-7. doi: 10.1345/aph.1D128. Epub 2004 Jan 30.
To describe the first case, to the best of our knowledge, of posttraumatic Scedosporium apiospermum (ScA) keratitis successfully treated with systemic and topical voriconazole.
A 19-year-old man was admitted to the hospital with an incisive wound of his left eye and the cornea totally sectioned after trauma with a cutter used in gardening. Initial empirical treatment was followed by systemic and topical voriconazole, and the eye did not have to be enucleated. Five months after the trauma, a penetrating keratoplasty and chamber intraocular lens implantation was performed with a favorable visual outcome.
ScA keratitis is rare, but it must be suspected if a history of ocular injury with contaminated objects exists. Among the antifungals available to treat ScA keratitis, voriconazole has shown advantages such as the lowest minimum inhibitory concentration and the availability of an oral formulation.
Voriconazole shows promise as an effective alternative to conventional antifungals in the treatment of ScA keratitis. It is available both as oral and intravenous preparations, which is a great advantage in these lengthy infections.
据我们所知,描述首例成功采用全身及局部伏立康唑治疗的创伤后阿利什霉角膜炎病例。
一名19岁男性因左眼锐器伤入院,其角膜在使用园艺刀具创伤后完全切断。初始经验性治疗后采用全身及局部伏立康唑治疗,眼球无需摘除。创伤后5个月,进行了穿透性角膜移植术及前房人工晶状体植入术,视觉效果良好。
阿利什霉角膜炎罕见,但如果存在眼部被污染物体损伤史,则必须怀疑该病。在可用于治疗阿利什霉角膜炎的抗真菌药物中,伏立康唑已显示出优势,如最低抑菌浓度最低且有口服制剂。
伏立康唑有望成为治疗阿利什霉角膜炎的传统抗真菌药物的有效替代药物。它有口服和静脉制剂,这在这些病程较长的感染中是一大优势。